These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 36613689)

  • 1. Activation of Transposable Elements in Human Skeletal Muscle Fibers upon Statin Treatment.
    Valdebenito-Maturana B; Valdebenito-Maturana F; Carrasco M; Tapia JC; Maureira A
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systems biology strategy reveals biological pathways and plasma biomarker candidates for potentially toxic statin-induced changes in muscle.
    Laaksonen R; Katajamaa M; Päivä H; Sysi-Aho M; Saarinen L; Junni P; Lütjohann D; Smet J; Van Coster R; Seppänen-Laakso T; Lehtimäki T; Soini J; Oresic M
    PLoS One; 2006 Dec; 1(1):e97. PubMed ID: 17183729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of simvastatin on cholesterol metabolism in C2C12 myotubes and HepG2 cells, and consequences for statin-induced myopathy.
    Mullen PJ; Lüscher B; Scharnagl H; Krähenbühl S; Brecht K
    Biochem Pharmacol; 2010 Apr; 79(8):1200-9. PubMed ID: 20018177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The AKT/mTOR signaling pathway plays a key role in statin-induced myotoxicity.
    Bonifacio A; Sanvee GM; Bouitbir J; Krähenbühl S
    Biochim Biophys Acta; 2015 Aug; 1853(8):1841-9. PubMed ID: 25913013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statin-induced myopathy in the rat: relationship between systemic exposure, muscle exposure and myopathy.
    Sidaway J; Wang Y; Marsden AM; Orton TC; Westwood FR; Azuma CT; Scott RC
    Xenobiotica; 2009 Jan; 39(1):90-8. PubMed ID: 19219751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statins induce skeletal muscle atrophy via GGPP depletion-dependent myostatin overexpression in skeletal muscle and brown adipose tissue.
    Wang L; Zheng ZG; Meng L; Zhu L; Li P; Chen J; Yang H
    Cell Biol Toxicol; 2021 Jun; 37(3):441-460. PubMed ID: 33034787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statin activation of skeletal ryanodine receptors (RyR1) is a class effect but separable from HMG-CoA reductase inhibition.
    Lindsay C; Musgaard M; Russell AJ; Sitsapesan R
    Br J Pharmacol; 2022 Nov; 179(21):4941-4957. PubMed ID: 35703154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Risk of Muscular Events Among New Users of Hydrophilic and Lipophilic Statins: an Observational Cohort Study.
    Mueller AM; Liakoni E; Schneider C; Burkard T; Jick SS; Krähenbühl S; Meier CR; Spoendlin J
    J Gen Intern Med; 2021 Sep; 36(9):2639-2647. PubMed ID: 33751411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A survey of the FDA's AERS database regarding muscle and tendon adverse events linked to the statin drug class.
    Hoffman KB; Kraus C; Dimbil M; Golomb BA
    PLoS One; 2012; 7(8):e42866. PubMed ID: 22936996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of mitochondria in statin-induced myopathy.
    Apostolopoulou M; Corsini A; Roden M
    Eur J Clin Invest; 2015 Jul; 45(7):745-54. PubMed ID: 25991405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact of Exercise on Statin-Associated Skeletal Muscle Myopathy.
    Chung HR; Vakil M; Munroe M; Parikh A; Meador BM; Wu PT; Jeong JH; Woods JA; Wilund KR; Boppart MD
    PLoS One; 2016; 11(12):e0168065. PubMed ID: 27936249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SLCO1B1 polymorphism is not associated with risk of statin-induced myalgia/myopathy in a Czech population.
    Hubáček JA; Dlouhá D; Adámková V; Zlatohlavek L; Viklický O; Hrubá P; Češka R; Vrablík M
    Med Sci Monit; 2015 May; 21():1454-9. PubMed ID: 25992810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between SLCO1B1 T521C polymorphism and risk of statin-induced myopathy: a meta-analysis.
    Xiang Q; Chen SQ; Ma LY; Hu K; Zhang Z; Mu GY; Xie QF; Zhang XD; Cui YM
    Pharmacogenomics J; 2018 Dec; 18(6):721-729. PubMed ID: 30250148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A statin-dependent QTL for GATM expression is associated with statin-induced myopathy.
    Mangravite LM; Engelhardt BE; Medina MW; Smith JD; Brown CD; Chasman DI; Mecham BH; Howie B; Shim H; Naidoo D; Feng Q; Rieder MJ; Chen YD; Rotter JI; Ridker PM; Hopewell JC; Parish S; Armitage J; Collins R; Wilke RA; Nickerson DA; Stephens M; Krauss RM
    Nature; 2013 Oct; 502(7471):377-80. PubMed ID: 23995691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of multi-drug resistance-associated protein-1 transporter in statin-induced myopathy.
    Dorajoo Rs; Pereira BP; Yu Z; Gopalakrishnakone P; Leong CC; Wee A; Lee E
    Life Sci; 2008 Apr; 82(15-16):823-30. PubMed ID: 18509883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simvastatin monotherapy as a potential option for statin-associated muscle symptoms: a case report.
    Qu H; Guo M; Kou N; Wu HT; Zhang Y; Gao ZY; Shi DZ
    J Clin Pharm Ther; 2016 Oct; 41(5):568-71. PubMed ID: 27425755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statin therapy induces ultrastructural damage in skeletal muscle in patients without myalgia.
    Draeger A; Monastyrskaya K; Mohaupt M; Hoppeler H; Savolainen H; Allemann C; Babiychuk EB
    J Pathol; 2006 Sep; 210(1):94-102. PubMed ID: 16799920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SLCO1B1 variants and statin-induced myopathy--a genomewide study.
    ; Link E; Parish S; Armitage J; Bowman L; Heath S; Matsuda F; Gut I; Lathrop M; Collins R
    N Engl J Med; 2008 Aug; 359(8):789-99. PubMed ID: 18650507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients experiencing statin-induced myalgia exhibit a unique program of skeletal muscle gene expression following statin re-challenge.
    Elam MB; Majumdar G; Mozhui K; Gerling IC; Vera SR; Fish-Trotter H; Williams RW; Childress RD; Raghow R
    PLoS One; 2017; 12(8):e0181308. PubMed ID: 28771594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative stress as a possible mechanism of statin-induced myopathy.
    Ahmadi Y; Ghorbanihaghjo A; Naghi-Zadeh M; Yagin NL
    Inflammopharmacology; 2018 Jun; 26(3):667-674. PubMed ID: 29574631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.